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Since its discovery and purification in the 1960s, Green Fluorescent Protein has quickly 
become an extremely useful scientific tool for analyzing protein expression and dynamics.  GFP 
was originally discovered in a species of jellyfish, Aequorea victoria, apparent only in response 
to a blue flash of bioluminescence.  Upon examining its structure, scientists soon found that the 
source of GFP’s color was an autocatalytically formed chromophore at the center of its β-barrel 
structure.  Because of this autocatalytic mechanism of fluorescence, the GFP gene alone can be 
attached to proteins of interest and used to track expression and movement in vivo.   
While GFP itself was a breakthrough in the biotechnology world, it is hardly the end of 
the line as far as fluorescent proteins go.  In recent years, scientists have been searching for and 
finding more members of the GFP-family that have the same autocatalytic property but display 
different colors.  The introduction of new colors to the library of fluorescent proteins offers great 
advantages in multiple protein tagging and studying protein interactions.  However, most 
fluorescent proteins that have been found to date have been tetramers, consisting of four identical 
subunits.  This quaternary structure makes them ineffective as protein tags. 
Researchers have recently been exploring ways to alter the oligomerization state of 
fluorescent proteins and create dimeric and monomeric forms the can be useable tags.  In my 
experiment, I attempted to do so in a GFP family protein from species Galaxea fascicularis and 
Montipora efflorescens known as purple protein.  There is not a protein tag that emits is colored 
purple currently, and so my goal was to reduce the oligomerization state of purple protein, 
assuming that it is a tetramer, while maintaining its purple color.  To do this, I used site-directed 
mutagenesis techniques to change specific amino acids in the protein that were predicted to be 
involved in formation of tetramers.   
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All three mutations made in the sequence affected the spectral qualities, as the cells they 
that the mutants were transformed into showed no purple expression.  One mutation resulted in a 
protein that migrated at half the relative molecular weight of the wild type protein in a gel 
filtration column, and thus we were successful in reducing the oligomerization state of the purple 
protein through that mutation.  While it is not currently useful as tag, the successful mutant 
should be used in future experiments to isolate a functional monomer of the purple protein, 






















 Green Fluorescent Protein (GFP) was first discovered in a species of jellyfish, Aequorea 
victoria, and purified in the 1960s.  Scientists observed that, when exposed to blue light, the 
jellyfish emitted a green fluorescence.  (Matz, Lukyanov, & Lukyanov, 2002)  After isolating the 
protein, intensive study of its structure and function led to revolutionary discoveries that 
translated into breakthroughs in biotechnology, particularly with respect to the observation of 
protein expression and interactions.  While GFP initially seemed to be one of a kind, researchers 
have recently been in pursuit of an entire library of GFP-like proteins – those that display similar 
properties via the same mechanism as GFP, but differ in structural and spectral properties. (Matz, 
Lukyanov, & Lukyanov, 2002)  These GFP-like proteins offer the possibility of greater 
innovation in protein tracking techniques in vivo.  However, a typical problem that has come up 
in the study of these proteins is oligomerization  (Shaner, Patterson, & Davidson, 2007).  Due to 
the tetrameric quaternary structure of the majority of these proteins, their natural state is not 
conducive to using them as fluorescent tags for protein interaction and expression. (Tasdemir, et 
al., 2008)  Therefore, there is a great deal of research to be done on manipulating the structural 
character of many of these proteins to make them better tools for biologists and biochemists.  
 
Green Fluorescent Protein  
 Green Fluorescent Protein (GFP) is one of many fluorescent tools that have been used for 
tracking protein expression and interaction; however it has been recognized as one of the most 
valuable.  In the past, scientists have employed small organic fluorophore dyes for tracking 
proteins, but due to the dyes’ lack of specificity, antibodies are required to target proteins of 
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interest.  This requires the cells to be fixed and permeabilized, thus preventing the tracking of 
proteins in living cells.  Following that, phycobiliproteins were the first fluorescent proteins used 
in cell biology.  Phycobiliproteins are photosynthetic pigments found in cyanobacteria.  These 
macromolecules are brighter than the dyes since each protein contains multiple chromophores, 
but their use is limited by their large size.  Around 200 kDa, phycobiliproteins do not diffuse 
very well and have thus been mainly used for surface protein labeling. (Giepmans, Adams, 
Ellisman, & Tsien, 2006)  
With the discovery of GFP, many of the obstacles of protein expression imaging were 
overcome.  The new benefits of GFP were predominantly the result of its unique structure and 
mechanism for generating fluorescence.  The basic structure of a single GFP monomer is an 11-
stranded β-barrel with an α-helix running through the center of the cylinder [Figure 1-A]. (Yang, 
Moss, & Phillips, 1996) Unique to GFP (and the GFP-like family of proteins), the formation of 
the chromophore occurs autocatalytically during a post-translational protein maturation stage.  
(Pakhomov & Martynov, 2008)  Requiring only oxygen, inward-facing β-barrel sidechains 
containing a Serine-Tyrosine-Glycine sequence spontaneously react to create the basic GFP 
chromophore molecule: 4-(p-hydroxybenzylidene)-5-imidazolinone, referred to as p-HBI [Figure 





Figure 1.  (A)  Green Fluorescent Protein Structure: β-barrel, α-helix, and internal amino acid res idues;     
(B) Cycliza tion and Oxidation reactions to create  GFP basic structure, p-HBI, from tripeptide sequence   
[Borrowed from GFP Family: Structural Insights  into Spectral Tuning]  
 
 
 In addition to being able to serve as a reporter gene or selection marker (Tasdemir, et al., 
2008), the structure and functional properties of GFP make it an ideal tool for genetic protein 
tagging.  It can be covalently fused to just about any protein due to its bright fluorescence, 
autocatalytic chromophore formation, and the fact that it is genetically encoded.  This allows for 
precision in tagging, easy delivery to cells or organisms, and the ability to observe protein 
localization and expression in vivo.  (Giepmans, Adams, Ellisman, & Tsien, 2006)  In this 








 As with any great discovery, the finding of GFP led to an explosion of research and 
attempts to improve/expand the applications of GFP.  Initially, researchers worked to genetically 
alter GFP itself to produce other colors, as well as brighter, more versatile versions of itself (e.g, 
reduced oligomerization).  They were successful in creating blue, cyan, and yellow variants of 
GFP.  (Shaner, Patterson, & Davidson, 2007)  The second aspect of the pursuit, however, was the 
search for other fluorescent proteins (FPs) to be isolated from other organisms but having similar 
fluorescence as GFP.  Ideally, scientists wanted to find FPs with spectral properties that made 
them distinct (particularly, ones that emitted wavelengths that were distinguishable from the 
current GFP-like proteins available).  For a long time, scientists focused on bioluminescent 
systems only, expecting their similar physical properties to be indicative of similar structural 
bases.  However, many of these organisms were evolutionarily distant from the jellyfish species 
containing GFP, and in fact used systems far removed from that of GFP.  It was not until they 
branched out and explored non-bioluminescent organisms, such as corals, that they found natural 
GFP-like proteins that possessed the fluorescent capabilities and were visibly colored. (Matz, 
Lukyanov, & Lukyanov, 2002)  This breakthrough was followed by the discovery of several 
other FPs, most of which were non-bioluminescent but also fluorescent and colored, responsible 
for the pigment in the organisms that expressed them (Lukyanov, et al., 2000). 
 Members of the GFP family of proteins are similar to GFP, as would be expected, in their 
basic structure and mechanism of fluorescence.  They contain the same β-barrel structure 
surrounding the chromophore-containing α-helix.  The same autocatalytic mechanism is used to 
produce the chromophore, resulting in their color (linking them to GFP). (Matz, et al., 1999) 
What makes them appear different colors, however, is the chromophore structure itself.  It 
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appears that during chromophore synthesis, different organisms produce alternative chromophore 
products that have varying spectral qualities. (Labas, et al., 2002) It appears that the diversity 
results from chemical modifications to the p-HBI core after it has been synthesized.  (Pakhomov 
& Martynov, 2008)  
 
Importance of New Fluorescent Proteins  
 The technological implications of discovering these new, non-green FPs are very great.  
To reiterate, using GFP for in vivo labeling has quickly become one of the most popular 
biochemical techniques for analyzing protein expression and behavior in cells.  One of the big 
benefits of using genetic engineering to label proteins of interest within cells is that the label can 
have very little to no effect on the function of the protein or the cell itself.  (Schultz & Kohn, 
2008)  Until the discovery of GFP-like fluorescent proteins, however, technological innovation 
was very restricted because the library of colors available was limited to GFP and the mutant 
variants (e.g., cyan, yellow, and blue).  While the mutants allowed for some advancement, such 
as dual-color labeling and fluorescence resonance energy transfer (FRET) between colors for 
studying protein-protein interaction, there was not much beyond this that could be accomplished.  
(Matz, Lukyanov, & Lukyanov, 2002) 
 The expansion of fluorescent protein use due to the discovery of GFP-like proteins 
applies to single protein analysis as well as protein-protein interactions within cells.  I will 
briefly examine the techniques that have developed and/or benefited from the discovery of non-
green FPs before explaining the importance of adding to the library of usable fluorescent 
proteins.  The first aspect is the ability to analyze conformational changes within an individual 
protein.  Using fluorescence resonance energy transfer (FRET), scientists can flank a protein 
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between two marker proteins (i.e. two FPs of different spectral qualities) to detect changes in the 
conformation of the protein, such as if it undergoes phosphorylation.  The change is indicated by 
a shift in the FRET between the two FPs. (Giepmans, Adams, Ellisman, & Tsien, 2006) 
 The GFP family of proteins offers several advantages to protein-protein interaction 
observation.  For one, bimolecular fluorescent complementation (BiFC) is a technique that is 
used to study whether certain proteins interact with one another, and when that occurs.  The 
technique is possible because of the ability of GFP family proteins to reform their functional 
chromophores after being split and reunited.  In BiFC, an FP is split and each half is tagged to a 
different protein (typically two proteins that are thought to interact).  When the proteins are 
expressed, if/when they interact, the FP will come together and fluoresce, indicating the location 
and time of interaction.  Additionally, tagging multiple proteins with different colors allows us to 
examine protein interaction when they act in conjunction with one another (multi-color 
fluorescent correlation spectroscopy), for example, if two proteins diffuse simultaneously or in 
the same region. (Giepmans, Adams, Ellisman, & Tsien, 2006) 
 While the mutant variants of GFP have allowed for these innovations, finding additional 
colors will allow for even greater advancements.  For one, having a variety of FP reporters of 
different wavelengths will allow for versatility when it comes to looking at protein expression in 
different types of tissue and cells.  New colors offer potentially better visibility in cells that have 
problems with the expression of these proteins.  Additionally, multi-coloring makes it possible to 
observe multiple proteins at once being expressed or moving in the cells, thus saving time and 
money in the lab.  (Matz, Lukyanov, & Lukyanov, 2002)  This also applied to BiFC experiments, 
where multiple interactions can be observed at once.  Finally, new fluorescent proteins provide 
researchers with more FRET partner molecules, thus allowing for the study of higher order 
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complexes (i.e. protein interactions and the conformational changes that occur during the 
interactions).  (Giepmans, Adams, Ellisman, & Tsien, 2006)   
 
Engineering of GFP-like proteins  
 While the GFP family of proteins offers great advantages, there is one major problem that 
has been encountered.  So far, all proteins that have been investigated form very tight oligomers 
(usually consisting of at least 4 monomers, i.e. tetramers).  The complex quaternary structures of 
these proteins limits their use in FRET techniques (Matz, Lukyanov, & Lukyanov, 2002) and 
significantly limits their use as protein fusion tags.  (BD Biosciences, 2005)  Therefore, a major 
task for researchers involved in this field has been to find ways to prevent the oligomerization 
that occurs between the protein monomers (or at least reduce it) while retaining the fluorescent 
color expression.  This has been primarily attempted through modification of the amino acid 
sequences of the proteins through mutagenesis of the wild type DNA.  (Matz, Lukyanov, & 
Lukyanov, 2002) 
 In recent years, there have been successful attempts at genetically altering fluorescent 
proteins to reduce their oligomerization states.  One important achievement was the alteration of 
protein drFP583, also known as DsRed.  An interesting fact about DsRed is that it was the first 
known fluorescent protein that changes its emission color over time, making it an excellent 
indicator of time elapsed since a protein began being expressed when used as a reporter gene.  
(Matz, Lukyanov, & Lukyanov, 2002) The problem in its utility was that it, as usual, is a 
tetramer in nature.  Its strong oligomerization prevents it from being a useful protein tag.  (Baird, 
Zacharias, & Tsien, 2000)  However, scientists have been able to isolate to protein and mutate it 
to form a functional Ds-Red monomer, which is now marketed as a red fusion tag.  (BD 
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Biosciences, 2005)  A similar protein, HcRed, has also been converted from tetrameric form to a 
dimer. (Gurskaya, et al., 2001)  The methodology behind creating these monomers involves 
making site-specific amino acid mutations in the wild type proteins in order to disrupt those 
involved in oligomerization and prevent tetramerization from occurring.  This often requires 
several mutation attempts, and has required additional mutations to recover lost functions (e.g. if 
mutations prevent oligomerization but also eliminate or alter the spectral properties of the 
protein).  (Tasdemir, et al., 2008)  
 
Purple Protein  
 The protein I have been focused on a non-bioluminescent and non-fluorescent purple 
protein.  The two versions of the protein we have been working with come from the species 
Galaxea fascicularis and Montipora efflorescens.  This protein was discovered by Mikhail Matz, 
and it is assumed to be a tetramer due to the typical nature of these types of proteins.  When 
expressed, the purple protein gives cells a bright purple color.   
I decided to work with the purple protein because a purple colored protein has not yet 
been isolated and made viable for protein tagging, so my goal in this project was to introduce 
mutations into the purple protein sequence that would alter the oligomerization state.  In one 
respect, we hoped to find out/confirm if the oligomerization state of natural purple protein is 
actually a tetramer.  Additionally, assuming that it was a tetramer, we were attempting to make 
mutations that would prevent tetramerization and render it either a dimer or monomer while still 
maintaining the purple fluorescence of the wild type protein.  If a monomer (or dimer) was 
successfully engineered and exhibited the purple color in expression, we hoped that it could be 
made into a useful protein tagging tool to be added to the current library of monomeric 
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fluorescent proteins.  Additionally, it would be a useful tool for following the purification of 
tagged recombinant proteins from E. coli or other organisms. 
 
Project Overview  
 The project was designed so that three specific mutations would be made in the wild type 
purple protein, and that combinations of these mutations would also be made, so that there would 
be seven total mutant genes: three single mutants, three doubles, and one triple.  Deciding on the 
mutations to make could not be done solely based on the purple protein itself because the exact 
structure is currently unknown.  Therefore, the mutations were chosen by comparing the 
sequence of purple protein to that of a homologous protein, and using the structure of the 




Figure 2.  Structure  of a tetrameric 




The three residues selected to be mutated were amino acids known to be involved in the 
tetramer formation in the purple homolog (e.g., the formation of salt bridges) [Figure 3]: 
1) Threonine at amino acid position 102 was changed to a lysine (mutation T102K). 
2) Arginine at amino acid position 149 was changed to a glutamic acid (mutation 
R149E). 
3) Phenylalanine at amino acid position 158 was changed to a lysine (mutationF158K). 
 
Figure 3. Image of tetrameric interactions of purple prote in homolog.  The involvement of residues  F158 and R149 
can be seen.  
  
The plasmid chosen as the purple protein vector was pET-16b, which contains an 
ampicillin resistance gene for screening purposes.  The vector also has a HIS-tag so that it can be 
purified and analyzed after mutagenesis and transformation.  Once the mutations were made, the 
plan was to transform the mutant-containing plasmids into high-efficiency protein expression 
cells, and then check for expression of the purple color and isolate the mutant proteins for 





Methods and Materials 
 
Site-Directed Mutagenesis  
 Mutations were introduced into the purple protein gene through PCR reactions using site-
specific mutant primers.  Two different vectors containing the gene were used as templates for 
the PCR reactions: pET-16b and pET-22b(+).  Primers for the three mutations were engineered 
to be identical to the purple protein gene with the exception of the single codon that coded for the 
amino acid to be changed (see Appendix for primer sequences).  In creating multiple mutations 
on one gene, single mutants were used as the templates for double mutants, and a double mutant 
was used as the template to introduce a third mutation.   
 The PCR reactions consisted of 10X PCR reaction buffer, 10X dNTPs, 125 ng of forward 
primer, 125 ng of reverse primer, and 100 ng of template.  One unit of Pfu DNA polymerase was 
used per reaction, and each reaction was a total of 50 µl in a PCR tube.  The times and 
temperatures for the program used were the following: 
1.  95° C for one minute 
2. 18 cycles of: 50 second denaturing at 95° C, 50 second annealing at 57.6° C, 9.5 minute 
polymerization at 70° C 
3. 70° C for seven minutes 
4. Hold at 4° C until removed 
 
Note:  57.6° C was used as the annealing temperature for most mutations.  However, when 
this temperature failed to produce product, a gradient of annealing temperatures was used, 





 In order to eliminate the template before transforming the products into E. coli, each PCR 
reaction was digested with DpnI.  For each 50 µl reaction, 0.5 µl (10 units) of DpnI was added.  
The contents were mixed using a pipette, and then each tube was centrifuged for one minute at 
4000 RPM to pool the contents at the bottom.  The mixtures were then incubated in a 37° C 
water bath for an hour.   
 
Gel Electrophoresis 
 To analyze DpnI digestions (as well as restriction digests), analytical agarose gels were 
used, composed of 1% agarose and 50 ml of 1X TAE buffer with 1 µl of 10 mg/ml ethidium 
bromide.  Typically, 10 µl of each sample was combined with 2 µl of 5X loading dye.  Each gel 
was run at a constant voltage of 100V for one hour, with the samples alongside a 1 KB size 
standard. 
 
XL-10 Gold Transformation 
 Each PCR product was transformed into XL-10 Gold E. coli cells to screen for mutants.  
100 µl of XL-10 Gold cells was added to 15 µl of PCR product, which was then incubated on ice 
for 30 minutes.  All 115 µl were plated on 2XYT + Ampicillin plates and incubated at 37° C for 
16-24 hours.   
 
DNA Purification  
 For each transformation, isolated colonies were picked and inoculated in 3 ml of 2XYT 
medium containing 450 µg of Ampicillin.  These cultures were grown 16-24 hours.  The next 
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day, 1.5 ml of each culture was centrifuged at 5000 RPM for one minute.  The DNA was purified 
from the cultures using Sigma DNA Miniprep Kit.   
 
Restriction Digest 
 Restriction digests using enzyme PvuII were done to assay for the expected DNA 
fragment sizes (based on the non-mutant purple gene contained in the plasmids as a control).  
The reactions contained 10X NEB Buffer 2, three units of enzyme PuvII, and 3 µl of the 
miniprepped DNA.  Each digest contained a total volume of 10 µl.  (The volume was brought up 
to 10 µl with double-distilled water.)  The reactions were then incubated in a 37° C water bath 
for one hour.  After incubation, 2 µl of 5X loading dye was added to each sample, and all 12 µl 
were run on a 1% agarose gel.  
 
DNA Sequencing  
Using the restriction digest for comparison to the control, clones that looked to be 
positive for the plasmid vector were sequenced.  500 ng of each DNA miniprep was aliquoted 
and sequenced by the ICMB sequencing facility using T7 primers.  The sequences were 
compared to the expected mutant sequences for verification of mutations.   
 
Protein Expression 
 Verified mutant DNA strains were transformed into BL21 (DE3) E. coli cells for high-
efficiency protein expression.  1 ng of each mutated construct was added to 25µl of BL21 (DE3) 
cells, and the transformation reaction was incubated on ice for 30 minutes.  The mixtures were 
then plated on 2XYT + Ampicillin plates and incubated at 37° C for 16-24 hours.  The following 
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day, an isolated colony from each plate was streaked onto 2XYT + Ampicillin + IPTG plates to 
induce expression.  (Prior to colony streaking, 8 µl of 1 M IPTG was spread on the surface of the 
plates.)  The plates containing IPTG (as well as non-IPTG streak plates, used as controls) were 
incubated at 37° C with exposure to white light for 16-24 hours. 
 
IPTG Concentration Gradient 
 To test for the best concentration of IPTG in inducing purple protein expression, a time 
course was set up using the non-mutant purple control and the triple mutant as test samples.  Five 
overnight cultures were grown (containing 3 ml 2XYT + 450 µg Ampicillin) for both the control 
and the mutant clones.  The following day, each culture’s absorbance was measured and diluted 
to an OD of 0.10 at 600 nm (A600) in new media.  They were allowed to grow to an absorbance 
of about 0.45, at which point they were induced with one of five concentrations of IPTG: 0.05 
mM, 0.10 mM, 0.25 mM, 0.50 mM, and 1.00 mM.  The new cultures were incubated in light at 
37° C for 16-24 hours. 
 
Protein Purification 
 To test for the oligomerization state of the wild type and mutant proteins, the expressed 
proteins were purified from the cells.  A colony from each of the plasmid-containing BL21 
(DE3) cell transformations were inoculated in 3 ml of 2XYT + 450 µg Ampicillin media 
(mutants inoculated include all three single mutants and the triple mutant, as well as the wild 
type).  After growing the cultures for 18 hours, 2 ml of each culture was added to 200 ml of 
2XYT media + 600 µg Ampicillin in 1-liter flasks.  The cultures were grown to an OD of about 
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0.45, at which point IPTG was added at a concentration of 0.1 mM (20 µl of 1M IPTG).  These 
cultures were grown overnight (about 18 hours). 
The next day, each culture was centrifuged at 5000 RPM for 10 minutes in Oak Ridge 
tubes.  The supernatant was removed from the pellet, and the pellet was resuspended in a buffer 
(20 mM NaPO4 and 200 mM NaCl; pH 7), which was then transferred to a 50 ml conical vials 
and flash-frozen by submerging in liquid nitrogen.  In order to lyse the cells, the pellets were 
thawed in ice water and refrozen in liquid nitrogen a total of three times.  After the final thaw, 
the cells were sonicated using the full duty cycle on setting 7 for a total of 5 cycles (15 second 
sonication followed by 45 seconds of rest for each time).  Finally, the cells were refrozen once 
again in liquid nitrogen and stored in the -80° C freezer. 
The frozen cells were thawed in ice water.  2 µl of the whole cell suspension was 
aliquoted into a 1.5 ml Eppendorf tube (to run on a gel later) and preserved in the -80° C freezer.  
1.5 ml of 10% Triton X-100 was added to each batch of cells.  The lysed cells were centrifuged 
at 15,000 RPM for 20 minutes.  2 µl of the supernatant was removed and saved in the -80° C 
freezer. 
To purify the protein, Biorad Poly-Prep Chromatography Ni-NTA columns were used.  
All procedures were performed in a 4° C room, and 5-10 µl aliquots of each solution that flowed 
through the column (the sample, wash buffer, and eluted fractions) were removed and saved in 
the -80° C freezer to run on a gel.  First, the columns were prepared by adding 400 µl of Qiagen 
NiNTA beads, followed by 10 ml of a Column Preparation Solution (Resuspension Buffer, 10 
mM β-mercaptoethanol).  The supernatants from centrifugation were then passed through the 
column.  Then, each column was washed three times with 10 ml Wash Buffer (Resuspension 
Buffer, 10 mM β-mercaptoethanol, 25 mM Imidazole; pH 8).  The protein was eluted five times 
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with 200 µl of an Elution Buffer (Resuspension Buffer, 300 mM imidazole) into five separate 1.5 
ml Eppendorf tubes.   The 200 µl fractions were stored in the 4° refrigerator. 
 
Protein Gel 
 Samples taken from the flow through of the column were run on a Novex 4-20% and 
NuPAGE gel.  20 µl of 2X LDS Buffer was added to 2 µl of each of the whole cell suspension, 
soluble protein sample, and the sample flow through from the column.  5 µl of the buffer was 
added to 5 µl of each eluted fraction (in actuality, only the two most intensely purple – i.e. where 
the purple protein was most concentrated – fractions were run on the gel).  Therefore, for each 
mutant protein (and the wild type), five total samples were run on the protein gel (2 fractions, the 
whole cell, the soluble protein, and the flow through).  The samples were run alongside 
Invitrogen Benchmark Protein Ladder.  The gel was electrophoresed in SDS-PAGE protein 
running buffer at 200V for 41 minutes.   
 After electrophoresis, it was removed from its casing and fixed by placing it in a small 
container and submerging it in a solution of 50% methanol and 10% acetic acid.  The gel was 
kept in this solution for 15 minutes on a shaking plate.  Then, the gel was washed for 10 minutes 
(shaking) in ddH2O.  After washing, the gel was stained with a solution containing 20% 
methanol, 2% phosphoric acid, 10% ammonium sulfate, and 0.05% Coomassie G-250 overnight. 
 
 
Sephadex S200 Column Filtration  
 In order to determine the relative molecular weights of the mutant proteins (i.e. the 
oligomerization state relative to the wild type purple protein), a Sephacryl S200 Column was 
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used to separate the different sizes via gel-filtration.  The column separates proteins less than 200 
kDa.  One of the fractions for each mutant was selected and loaded onto the column.  Using 
Resuspension buffer, the fraction was passed through the column, and 2.5 ml fractions were 
collected.  A chart recorded the level of protein that was eluted into each fraction, indicating the 
relative sizes of the proteins in each sample. 
 
Western Dot Blot 
 A second test for protein size that was performed was the western dot blot.   From the 
Sephacryl S200 Column fractions, 250 µl from every third fraction for each mutant was 
aliquoted into a 1.5 ml Eppendorf tube.  A dot microfiltration apparatus was used to perform the 
dot blot, so in preparation, a sheet of nitrocellulose paper was cut to the size of the apparatus.  
The paper was washed for five minutes in ddH2O, and then washed for another five minutes in 
TBS (20 mM Tris – pH 7, 150 mM NaCl).  It was then set on top of the membrane, and the 96 
well plate was placed on top (and tightened).  The manifold was hooked up to a vacuum.  Each 
sample was loaded into one of the 96 wells, including a sample of the pure purple protein 
fraction (that had not been passed through the Sephacryl column) as a control.  The primary and 
secondary antibodies were incubated using the protocol for chemiluminescent substrates in the 
QIAexpress Detection and Assay Handbook.  The first antibody was diluted about 1:1300, and 
the second antibody used was goat anti-mouse IgG conjugated with horseradish peroxidase at a 
1:5000 dilution.  The signal was detected using chemiluminescence as described by the 
manufacturer (Perkin Elmer).  After completing the transfer, the dot blot was exposed on X-ray 






At the beginning of the project, we were using the pET-16b plasmid as the vector for 
purple-protein.  The first attempts at mutations were made using purple in pET-16b as the 
template [Figure 4].  After several successful mutations were made, we realized that purple was 
not being expressed in the transformed cells.  Assuming that it was a problem with the vector, we 
switched over to the pET-22b(+) vector and began redoing the mutations.  However, when we 
came across the same problem with the new construct, we were able to determine that the 
problem was with the cell line we were using.  For that reason, while we were able to introduce 
the complete set of mutations (all singles, doubles, and triple), the library of mutants consists of 
some in pET-16b and others in pET-22b(+).  In addition, the majority of PCR reactions were 
successful using an annealing temperature of 57.6° C, but we were unsuccessful creating the 
triple mutant at this temperature, and thus had to use a gradient.  We ended up getting the best 
result at 68° C annealing temperature.  Table 1 shows a complete list of the mutations made, the 
plasmids that they are in, and the annealing temperatures that worked for each. 
Mutation Vector Annealing Temperature 
T102K pET-22b(+) 57.6° C 
R149E pET-16b 57.6° C 
F158K pET-22b(+) 57.6° C 
T102K & R149E pET-16b 57.6° C 
T102K & F158K pET-22b(+) 57.6° C 
R149E & F158K pET-16b 57.6° C 
T102K & R149E& F158K pET-16b 68.0° C 
 




(A) (B) (C) (D)  
Figure 4.   DpnI digests of PCR reactions for mutations in pET-16b plasmid.  (A)  The far left lane contains  purified 
template of pET-16b containing the purple gene.  To the right of the 1 KB ladder are the PCR reactions of  
mutations (from left to right) T102K, R149E, and F158K.  The controls  on the fa r right show PCR reactions done 
without DNA polymerase.  (B) The PCR reaction and control for the double mutant: T102K & R149E.  (C) The PCR 
reaction and control for the double mutant: R149E & F158K.  (D)  The PCR reaction gradient for the triple mutant, 
where A, B, C, and D correspond to annealing temperatures of 68.0°C, 63.3°C, 57.6°C, and 55.0°C, respectively 




(A)  (B)  
 
 
Figure 5.  PvuII digests of plasmids after tra nsforming constructs into XL-10 Gold E. coli  cells and then purifying 
the DNA.  Each gel shows a 1 KB ladder followed by the non-mutant plasmid containing purple for comparison.  
(A) Sample of digests  of pET-16b clones.  “Mut 1.2” designates double mutation T102K and R149E.  “Mut 2.3” 
designates double mutation R149E and F158K.  (B)  Sample  of digests of pET-22b(+) clones.   “Mut 1” designates 
mutation T102K.  “Mut 2” designates mutation R149E.  
 
Using the PvuII restriction enzyme, we digested mutated constructs (purified from 
transformed XL-10 Gold E. coli cells) for comparison to non-mutants to make sure the correct 
plasmid was present.  The gels of the digests [Figure 5] showed us if there were any unexpected 
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bands or sizes of DNA fragments that resulted from mutations.  We chose certain clones for each 
mutant to sequence, and those that were correct were used for the high-efficiency protein 
expression transformations.  (See Appendix for sequences of the wild type purple gene and the 
theoretical mutant sequences.) 
We initially transformed our mutants and original plasmid into Rosetta Blue (DE3) E. 
coli cells.  After the first attempt showed no expression of purple protein by the positive control, 
we switched vectors (as stated before) and redid the mutagenesis and transformations.  When the 
problem persisted, we proceeded to do several tests.  We grew the cells on 2XYT + Ampicillin + 
Chloramphenicol plates containing IPTG and no IPTG.  The cells grew (without expressing 
purple) on the non-IPTG plates, but showed no growth on the plates containing IPTG.  We then 
tried to grow the cells in liquid media, inducing with varying concentrations of IPTG at an 
absorbance of OD = about 0.3, but still could see no positive results for the control.  At this 
point, we decided to switch to a different cell line – BL21 (DE3) E. coli cells.   
 
Purple Protein Expression 
Using the previously constructed mutants, we transformed all plasmids into BL21 (DE3) 
cells.  The result was that, on 2XYT + Ampicillin plates with IPTG, the purple control expressed 
the purple protein, but none of the mutants did.  We then did an IPTG concentration gradient, 
growing the cells in liquid cultures, to see if there was an optimal concentration for expression, 
and if the mutants required more or less IPTG than the wild type for expression.  Using total 
concentrations of 0.05 mM, 0.1 mM, 0.25 mM, 0.5 mM, and 1.0 mM, we found that the cells 
expressed the wild type purple in every concentrations (with relatively equal intensity), while 
none of the mutants turned purple at any of the concentrations. 
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Testing for Oligomerization States  
 In order to test for the relative sizes/oligomerization of the mutant and wild type proteins, 
we first had to grow large cultures of the cells the contained the appropriate plasmids and purify 
the proteins from them.  We decided to do so with only the single mutants and the triple mutant 
to see what the effects of each mutation were, and if the combination of all mutations caused 
some change that they did not do individually.  The overnight culture of mutation R149E, 
however, did not grow, so it is excluded from these results. 
 After purification of the protein through the Ni-NTA columns, we collected five 200 µl 
fractions containing the protein.  Based on the control, we chose the two fractions that appeared 
to contain the most protein (e.g., the two fractions from the control that were the most intensely 
purple were the fractions we used for each mutant).  These fractions were numbers two and 
three.  We then ran each of the samples we had collected from the purification on protein gels, 
including a whole cell sample, the soluble protein sample after centrifugation, the flow through 
from the column, and fractions two and three for each protein.  It is clear from the gel [Figure 6] 
that the wild type purple protein is at a much higher concentration than the mutants.  We can also 
see that the mutants have dark bands at the same position that the purple protein showed up in 




Figure 6.  Protein gels of fractions 2 and 3 of each of the  wild type purple prote in, mutation T102K, 
mutation F158K, and the triple muta nt.  The top label for the la nes indicates the mutant (or wild type) 
that the samples come from, and the important lanes under each heading are the two labeled “2” and “3” 




Sephacryl S200 Column Chromatography 
 One fraction of each of the mutant and wild type proteins were passed through the 
Sephacryl S200 Column.  The column separated the proteins in each sample by relative 
molecular weight, eluting the proteins into 60 2.5-ml fractions.  As the samples passed through 
the column and were eluted into the fractions, the relative amounts of protein coming out at each 
point were recorded onto a chart.  The data showed a large peak during the elution for the wild 
type protein, indicating the time when it eluted from of the column, and thus giving us a size 




Figure 7.  Sephadex S200 Column recording for wild type purple protein.   
 
 
 In the figure, the elution fractions are marked along the x-axis (of time, in minutes), and 
the absorbance reading is on the y-axis.  While the control showed a clear and significant peak, 
the readings for all of the three mutants showed no significant peaks, and their charts were 
comparable to that of buffer being run through the column.  Therefore, there was insufficient 
material to determine from the chart what the relative oligomerization states of the mutants were. 
 
Western Dot Blot 
 Because the protein level was too low for the Sephacryl 200 to give clear results, the 
western dot blot was done as a more sensitive alternative test.  By using antibodies and 
chemiluminescence, we were able to view the relative concentrations of protein across the 60 
fractions by looking at how intensely the dots for each sample are across the gradient.  For the 
dot blot, we used every third fraction (so a total of 20 samples) as our interval.  From the image 
[Figure 8], the gradient for the wild type purple protein seems to have two “peaks” of brightness.  
However, the second peak can be considered degraded protein because it is around the last 
fractions to be eluted and did not show up on the Sephadex chart.  The area that is important – 
the first bright peak – appears around 50 ml during the elution (the center dot of the peak is 
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circled in red).  Based on a size standard, we were able to calculate that, according to that data, 
the purple wild type protein is about 65 kDa in size. 
 
 
 Continuing to look at the X-ray image, we can see that mutation T102K has the same 
major peak as the wild type above it, indicating that it is relatively the same molecular weight.  
However, looking at mutation F158K, it appears that the peak has shifted downstream 
significantly (see that the red circle around the approximate center of the peak is not at the same 
location as the other mutation or the wild type purple).  By comparing this to a standard, we can 
tell that the mutant containing F158K is about 32 kDa – therefore, it is about half the size of the 
purple wild type.  For the triple mutant at the bottom of the image, the expression is too low to 
indicate a signal anywhere, so nothing can be concluded about its size.  (Recall that on the 





Figure 8.  Western Dot Blot of  wild type 
purple protein and mutant proteins.  The 
dots represent every third fraction, 
starting from the top left and ending at the 
bottom right of  each box.  The red circles 
indicate  the  approximate  centers of  the 
peaks where the fractions  gave the 






 According to the results, both mutations T102K and F158K affected the spectral qualities 
of purple protein and prevented cells from expressing the purple color.  Due to the low signal 
from the protein purification experiments, this may partially be due to the lower expression of 
purple protein itself.  In fact, during the purification process, mutation T102K exhibited a pale 
purple color on the Ni-NTA columns, indicating a low level of purple, and this mutant was the 
one with the highest level of expression (after the wild type purple). It could also involve the 
mutations causing a change in the chromophore itself, such as its structure or maturation time. 
 With regard to oligomerization state, mutation T102K was unchanged during the 
experiment, as shown by the western dot blot test.  Mutation F158K, on the other hand, altered 
the oligomerization state of the purple protein.  From the dot blot, we found that the peak for this 
mutation’s elution from the Sephadex S200 column showed it to be half the size of the wild type 
protein.  This leads us to several conclusions, one being that the oligomerization state of purple 
protein is greater than one.  We can also conclude that, using this specific mutation, we can 
reduce the oligomerization state, making it a more manageable size for protein tagging 
experiments.  However, we cannot definitively say whether the change in oligomerization state 
was a shift from a tetramer (wild type) to a dimer (F158K mutant) or a shift from a dimer to a 
monomer.  Further experimentation, for example using analytical ultrcentrifugation, will allow 
us to definitively determine the mass and oligomerization state of these proteins.   
 In its current state, the reduced purple protein is still not as useful as a protein tagging 
tool as we would like.  However, future research will be done to recover the spectral properties 
the F158K mutant.  Through this project, we were able to create a protein of a more manageable 
structure that may eventually be a new color of protein fusion tag.  From here, random 
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mutagenesis experiments should be done using the mutant as a template.  Once they are 
transformed into high-efficiency protein expression cells, the purple colonies can be selected and 
screened for oligomerization state (through protein purification and filtration).  If a successful 
clone can be found, then by purifying its DNA and attaching it to a protein of interest, it can be 






















Purple Wild Type and Mutant Sequences 
* Locations of the mutations made are highlighted.  See KEY below for which mutation each 
color indicates. 
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